NCT01659645View on ClinicalTrials.gov

Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Breast Cancer
Interventions
DRUG

FACBC

Drug FACBC will be given intravenously (IV) over 2 minutes prior to performing the PET scan

Trial Locations (1)

30322

Emory University, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT01659645 - Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast | Biotech Hunter | Biotech Hunter